Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.31 trillion and total revenue of $119.82 billion.
Market Cap
1.31T
Revenue
119.82B
Profits
-33.41B
PE Ratio
n/a
Profit Margin
-27.88%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 142.95B | 0.92% | 972,432 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 97.40B | 4.61% | 832,348 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 89.83B | 1.48% | 4,379,873 | 2.23B |
| 4 | ARGX | argenx SE | 55.86B | -0.90% | 107,559 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 41.29B | -1.94% | 133,228 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 40.88B | -0.29% | 406,435 | - |
| 7 | RPRX | Royalty Pharma plc | 38.41B | -0.57% | 846,602 | 2.54B |
| 8 | GMAB | Genmab A/S | 34.21B | -2.02% | 1,983,835 | 4.13B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.19B | -1.76% | 1,939,765 | 7.53M |
| 10 | INSM | Insmed Incorporated | 24.38B | -1.28% | 874,007 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.30B | -0.96% | 528,002 | 6.01B |
| 12 | BNTX | BioNTech SE | 22.06B | -0.40% | 215,838 | 3.03B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.54B | -2.52% | 2,053,910 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 17.46B | 3.14% | 2,267,675 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 16.51B | 0.05% | 134,233 | 1.20B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.77B | 1.17% | 1,305,166 | 945.54M |
| 17 | HALO | Halozyme Therapeutics, Inc. | 14.64B | -1.46% | 861,802 | 1.66B |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 14.00B | -0.13% | 289,313 | 4.60B |
| 19 | SMMT | Summit Therapeutics Inc. | 12.05B | -5.99% | 1,624,551 | - |
| 20 | TECH | Bio-Techne Corporation | 11.40B | 0.03% | 1,023,941 | 1.22B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.27B | -0.51% | 714,605 | 3.41B |
| 22 | KYMR | Kymera Therapeutics, Inc. | 10.91B | 0.91% | 495,094 | 102.24M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.94B | -0.01% | 150,472 | 1.28B |
| 24 | PCVX | Vaxcyte, Inc. | 9.58B | -1.90% | 383,778 | - |
| 25 | CAI | Caris Life Sciences, Inc. | 9.25B | -4.63% | 1,091,987 | 989.61M |
| 26 | PTGX | Protagonist Therapeutics, Inc. | 9.14B | -2.47% | 115,560 | 281.99M |
| 27 | SYRE | Spyre Therapeutics, Inc. | 8.94B | -0.94% | 246,438 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 8.75B | -0.05% | 238,274 | 67.67M |
| 29 | CORT | Corcept Therapeutics Incorporated | 8.75B | -0.25% | 566,379 | 830.81M |
| 30 | TGTX | TG Therapeutics, Inc. | 8.64B | -0.46% | 1,075,692 | 799.54M |
| 31 | IBRX | ImmunityBio, Inc. | 8.52B | -3.02% | 3,808,190 | 165.79M |
| 32 | KRYS | Krystal Biotech, Inc. | 8.47B | -13.85% | 571,501 | 470.03M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.46B | -0.05% | 448,976 | 669.50M |
| 34 | TWST | Twist Bioscience Corporation | 8.43B | -11.96% | 1,415,701 | 431.80M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 7.77B | -2.62% | 43,744 | 7.46M |
| 36 | ABVX | ABIVAX Société Anonyme | 7.54B | -1.95% | 418,379 | 5.33M |
| 37 | AXSM | Axsome Therapeutics, Inc. | 6.97B | -7.85% | 1,588,551 | 865.27M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 6.96B | -3.77% | 682,326 | 874.09M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.50B | 1.93% | 618,739 | 239.92M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 6.35B | -0.99% | 215,703 | - |
| 41 | LGND | Ligand Pharmaceuticals Incorporated | 6.24B | -3.31% | 98,199 | 253.83M |
| 42 | BLTE | Belite Bio, Inc | 6.23B | -0.03% | 53,700 | - |
| 43 | KOD | Kodiak Sciences Inc. | 6.02B | -3.28% | 104,684 | - |
| 44 | IMVT | Immunovant, Inc. | 6.01B | -0.27% | 226,439 | - |
| 45 | MANE | Veradermics, Incorporated | 5.57B | -4.56% | 181,968 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.54B | 0.29% | 133,503 | 618.07M |
| 47 | CGON | CG Oncology, Inc. | 5.50B | -3.99% | 219,006 | 6.23M |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.33B | -0.36% | 204,871 | - |
| 49 | COGT | Cogent Biosciences, Inc. | 5.23B | -2.79% | 519,818 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.06B | 1.03% | 418,866 | 1.16B |
| 51 | ERAS | Erasca, Inc. | 4.97B | -0.91% | 2,209,238 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 4.88B | -1.87% | 295,124 | 13.39M |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.66B | -1.91% | 801,731 | 591.33M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.60B | -0.07% | 167,841 | 1.90M |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.53B | -7.16% | 711,433 | - |
| 56 | LEGN | Legend Biotech Corporation | 4.14B | -1.34% | 504,519 | 1.27B |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.13B | -2.28% | 384,895 | - |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 4.02B | -0.16% | 547,259 | 463.98M |
| 59 | TNGX | Tango Therapeutics, Inc. | 3.83B | - | 1,284,927 | 53.81M |
| 60 | RLAY | Relay Therapeutics, Inc. | 3.83B | -4.85% | 918,981 | 10.35M |
| 61 | ABCL | AbCellera Biologics Inc. | 3.70B | -6.93% | 1,463,979 | 66.17M |
| 62 | XENE | Xenon Pharmaceuticals Inc. | 3.68B | 1.58% | 551,567 | 7.50M |
| 63 | IOVA | Iovance Biotherapeutics, Inc. | 3.62B | -5.78% | 11,213,542 | 324.97M |
| 64 | IRON | Disc Medicine, Inc. | 3.52B | -2.03% | 133,265 | - |
| 65 | ACAD | Acadia Pharmaceuticals Inc. | 3.51B | -1.07% | 296,454 | 1.14B |
| 66 | VKTX | Viking Therapeutics, Inc. | 3.42B | -1.58% | 1,547,934 | - |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.37B | -3.73% | 173,547 | 148.00K |
| 68 | CELC | Celcuity Inc. | 3.33B | -1.68% | 278,131 | - |
| 69 | ELVN | Enliven Therapeutics, Inc. | 3.25B | 0.16% | 262,800 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.23B | -1.78% | 66,811 | 606.33M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.18B | 2.10% | 898,267 | - |
| 72 | TLX | Telix Pharmaceuticals Limited | 3.14B | 0.44% | 105,886 | 890.79M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 3.03B | -1.66% | 72,525 | 234.13M |
| 74 | DNLI | Denali Therapeutics Inc. | 2.99B | -1.14% | 316,981 | 3.60M |
| 75 | VRDN | Viridian Therapeutics, Inc. | 2.82B | 1.07% | 1,041,388 | 71.13M |
| 76 | NRIX | Nurix Therapeutics, Inc. | 2.82B | -3.77% | 729,538 | 701.94M |
| 77 | ZLAB | Zai Lab Limited | 2.71B | -1.04% | 80,798 | 449.61M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.64B | -2.94% | 376,882 | 156.04M |
| 79 | MBX | MBX Biosciences, Inc. | 2.63B | -2.29% | 101,783 | - |
| 80 | RCUS | Arcus Biosciences, Inc. | 2.58B | -1.26% | 354,463 | 117.00M |
| 81 | ADMA | ADMA Biologics, Inc. | 2.56B | 0.09% | 793,394 | 512.28M |
| 82 | NAMS | NewAmsterdam Pharma Company N.V. | 2.38B | -0.65% | 546,725 | 7.12M |
| 83 | PHVS | Pharvaris N.V. | 2.35B | -0.36% | 170,350 | - |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.34B | -2.73% | 9,995,351 | 54.86M |
| 85 | BHVN | Biohaven Ltd. | 2.32B | -0.19% | 598,029 | - |
| 86 | VERA | Vera Therapeutics, Inc. | 2.30B | 3.13% | 819,600 | - |
| 87 | CLDX | Celldex Therapeutics, Inc. | 2.28B | -3.47% | 219,408 | 158.00K |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 2.25B | -0.36% | 144,487 | 959.90M |
| 89 | XNCR | Xencor, Inc. | 2.23B | 0.70% | 463,985 | 104.97M |
| 90 | IMNM | Immunome, Inc. | 2.21B | 6.86% | 915,397 | 4.02M |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -2.16% | 565,517 | 321.74M |
| 92 | PVLA | Palvella Therapeutics, Inc. | 2.12B | 0.55% | 99,326 | - |
| 93 | VCEL | Vericel Corporation | 2.05B | -0.55% | 158,290 | 306.30M |
| 94 | LKFT | Lakefront Biotherapeutics NV | 2.05B | -0.90% | 116,516 | 1.13B |
| 95 | ZYME | Zymeworks Inc. | 2.03B | 0.17% | 193,638 | 37.13M |
| 96 | SEPN | Septerna, Inc. | 1.99B | -3.34% | 94,585 | 98.88M |
| 97 | FTRE | Fortrea Holdings Inc. | 1.96B | -4.63% | 430,160 | 2.67B |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 1.94B | -1.50% | 237,051 | 1.97B |
| 99 | COAG | Hemab Therapeutics Holdings, Inc. | 1.93B | -0.31% | 138,282 | - |
| 100 | MESO | Mesoblast Limited | 1.93B | -2.31% | 101,291 | 120.25M |
| 101 | TRVI | Trevi Therapeutics, Inc. | 1.93B | -0.26% | 342,786 | - |
| 102 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.92B | -5.25% | 442,411 | 208.78M |
| 103 | PGEN | Precigen, Inc. | 1.90B | -23.70% | 8,716,429 | 85.72M |
| 104 | VIR | Vir Biotechnology, Inc. | 1.89B | -1.33% | 354,392 | 303.23M |
| 105 | TRAX | First Tracks Biotherapeutics, Inc. | 1.87B | -1.46% | 138,476 | - |
| 106 | ADRX | ADARx Pharmaceuticals, Inc. | 1.85B | -3.12% | 181,890 | 6.13M |
| 107 | AGIO | Agios Pharmaceuticals, Inc. | 1.84B | 0.98% | 545,625 | 98.34M |
| 108 | ZBIO | Zenas BioPharma, Inc. | 1.81B | -2.43% | 147,327 | 1.00M |
| 109 | GENB | Generate Biomedicines, Inc. | 1.77B | -4.77% | 372,818 | 26.48M |
| 110 | ABSI | Absci Corporation | 1.75B | -8.63% | 1,365,250 | 1.56M |
| 111 | REPL | Replimune Group, Inc. | 1.74B | 4.43% | 3,376,142 | - |
| 112 | SLS | SELLAS Life Sciences Group, Inc. | 1.74B | -10.85% | 5,561,957 | - |
| 113 | BRVE | Braveheart Bio, Inc. | 1.73B | -1.26% | 80,050 | - |
| 114 | STOK | Stoke Therapeutics, Inc. | 1.71B | 0.65% | 621,927 | 28.21M |
| 115 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -4.57% | 1,083,907 | 59.51M |
| 116 | NUVB | Nuvation Bio Inc. | 1.64B | -1.68% | 878,572 | 169.90M |
| 117 | URGN | UroGen Pharma Ltd. | 1.64B | 2.69% | 353,857 | 188.73M |
| 118 | MAZE | Maze Therapeutics, Inc. | 1.62B | -4.46% | 97,981 | 20.00M |
| 119 | QURE | uniQure N.V. | 1.61B | -6.44% | 4,298,480 | 18.67M |
| 120 | NVAX | Novavax, Inc. | 1.60B | -3.77% | 1,576,141 | 413.80M |
| 121 | RARE | Ultragenyx Pharmaceutical Inc. | 1.59B | 0.19% | 781,937 | 717.00M |
| 122 | KLRA | Kailera Therapeutics, Inc. | 1.58B | -5.21% | 194,497 | - |
| 123 | IMCR | Immunocore Holdings plc | 1.55B | -0.98% | 58,683 | 430.78M |
| 124 | LYCA | Lycia Therapeutics, Inc. | 1.55B | 2.08% | 67,153 | 4.44M |
| 125 | INVA | Innoviva, Inc. | 1.53B | -0.47% | 183,439 | 440.00M |
| 126 | GPCR | Structure Therapeutics Inc. | 1.50B | -4.07% | 164,732 | - |
| 127 | OCUL | Ocular Therapeutix, Inc. | 1.48B | -3.01% | 808,933 | 52.06M |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.47B | -1.10% | 654,501 | 20.00M |
| 129 | NBTX | Nanobiotix S.A. | 1.46B | -8.59% | 53,581 | 13.15M |
| 130 | MLYS | Mineralys Therapeutics, Inc. | 1.46B | -9.35% | 1,742,769 | - |
| 131 | TYRA | Tyra Biosciences, Inc. | 1.45B | 0.05% | 100,053 | - |
| 132 | ANAB | AnaptysBio, Inc. | 1.42B | -1.30% | 70,444 | 106.09M |
| 133 | KRSA | Korsana Biosciences, Inc. | 1.42B | 3.68% | 41,686 | - |
| 134 | GHRS | GH Research PLC | 1.39B | -2.85% | 80,386 | - |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.33B | 0.28% | 142,539 | - |
| 136 | TSHA | Taysha Gene Therapies, Inc. | 1.32B | -2.18% | 472,434 | 5.49M |
| 137 | KARD | Kardigan, Inc. | 1.32B | -0.42% | 105,342 | - |
| 138 | NKTR | Nektar Therapeutics | 1.30B | -2.03% | 137,707 | 54.59M |
| 139 | OMER | Omeros Corporation | 1.30B | -2.93% | 254,266 | 38.42M |
| 140 | LBRX | LB Pharmaceuticals Inc | 1.26B | -1.35% | 226,777 | - |
| 141 | VOR | Vor Biopharma Inc. | 1.21B | -0.25% | 244,690 | - |
| 142 | AAPG | Ascentage Pharma Group International | 1.20B | -4.89% | 1,030 | 94.61M |
| 143 | SVRA | Savara Inc. | 1.20B | -2.39% | 577,470 | - |
| 144 | SLN | Silence Therapeutics plc | 1.19B | 0.08% | 510,534 | 615.00K |
| 145 | DRTS | Alpha Tau Medical Ltd. | 1.18B | -1.91% | 175,531 | - |
| 146 | VSTM | Verastem, Inc. | 1.18B | -0.51% | 647,638 | 87.53M |
| 147 | SNDX | Syndax Pharmaceuticals, Inc. | 1.16B | -4.62% | 920,115 | 252.25M |
| 148 | AVLN | Avalyn Pharma Inc. | 1.14B | 0.27% | 210,859 | - |
| 149 | MNKD | MannKind Corporation | 1.12B | -0.86% | 477,832 | 393.63M |
| 150 | SGP | SpyGlass Pharma, Inc. | 1.09B | 1.44% | 34,182 | - |
| 151 | JANX | Janux Therapeutics, Inc. | 1.08B | 1.03% | 147,879 | 24.00M |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.07B | 1.34% | 86,597 | 1.30M |
| 153 | SPTX | Seaport Therapeutics, Inc. | 1.06B | 1.28% | 297,552 | - |
| 154 | CTY | City Therapeutics, Inc. | 1.04B | 0.92% | 178,532 | 14.34M |
| 155 | IMTX | Immatics N.V. | 986.90M | 0.28% | 324,053 | 47.65M |
| 156 | MLTX | MoonLake Immunotherapeutics | 965.11M | -3.74% | 315,844 | - |
| 157 | ORIC | ORIC Pharmaceuticals, Inc. | 958.79M | 0.11% | 353,354 | - |
| 158 | CGEM | Cullinan Therapeutics, Inc. | 952.45M | -1.53% | 275,859 | - |
| 159 | RIGL | Rigel Pharmaceuticals, Inc. | 938.20M | -2.11% | 23,494 | 276.79M |
| 160 | ODTX | Odyssey Therapeutics, Inc. | 919.79M | -1.77% | 107,814 | 99.00K |
| 161 | LTGO | Latigo Biotherapeutics, Inc. | 907.97M | -1.83% | 109,579 | - |
| 162 | GLUE | Monte Rosa Therapeutics, Inc. | 907.31M | -1.16% | 267,433 | 28.73M |
| 163 | MGTX | MeiraGTx Holdings plc | 896.08M | -1.69% | 153,543 | 397.50M |
| 164 | IVA | Inventiva S.A. | 890.67M | 6.16% | 1,505,273 | 2.81M |
| 165 | PHAR | Pharming Group N.V. | 887.07M | 3.03% | 9,776 | 386.75M |
| 166 | KURA | Kura Oncology, Inc. | 883.38M | -3.22% | 353,172 | 77.23M |
| 167 | JBIO | Jade Biosciences, Inc. | 876.37M | -1.99% | 219,143 | - |
| 168 | ANRO | Alto Neuroscience, Inc. | 854.69M | -3.63% | 139,857 | - |
| 169 | OBX | Obsidian Therapeutics, Inc. | 852.47M | -6.69% | 166,548 | - |
| 170 | ALMS | Alumis Inc. | 829.68M | -4.75% | 479,139 | 7.40M |
| 171 | ABUS | Arbutus Biopharma Corporation | 823.05M | -1.19% | 411,438 | 181.72M |
| 172 | CRVS | Corvus Pharmaceuticals, Inc. | 818.50M | -2.99% | 165,594 | - |
| 173 | AKTS | Aktis Oncology, Inc. | 805.37M | -9.10% | 287,252 | 10.06M |
| 174 | PRME | Prime Medicine, Inc. | 792.56M | -5.61% | 1,983,697 | 4.07M |
| 175 | BBTX | Bambusa Therapeutics, Inc. | 779.42M | 2.07% | 152,566 | - |
| 176 | ARDX | Ardelyx, Inc. | 753.79M | -0.17% | 1,633,814 | 450.89M |
| 177 | OABI | OmniAb, Inc. | 751.91M | 0.88% | 847,927 | 40.21M |
| 178 | SLBT | SL Science Holding Limited | 749.90M | 9.58% | 6,136 | 3.27M |
| 179 | ANNX | Annexon, Inc. | 748.84M | -2.47% | 757,255 | - |
| 180 | SANA | Sana Biotechnology, Inc. | 727.45M | -5.45% | 1,113,012 | - |
| 181 | ATTO | Attovia Therapeutics, Inc. | 696.18M | 0.39% | 23,531 | 1.80M |
| 182 | WVE | Wave Life Sciences, Inc. | 693.26M | -2.09% | 533,162 | 70.92M |
| 183 | SGMT | Sagimet Biosciences Inc. | 691.00M | -1.76% | 342,622 | - |
| 184 | AVBP | ArriVent BioPharma, Inc. | 683.16M | -6.83% | 321,768 | - |
| 185 | HELP | Helus Pharma Inc. | 663.75M | -14.25% | 1,982,155 | - |
| 186 | ACHV | Achieve Life Sciences, Inc. | 663.72M | -5.56% | 724,623 | - |
| 187 | DNA | Ginkgo Bioworks Holdings, Inc. | 659.26M | -12.67% | 1,614,138 | 132.42M |
| 188 | DSGN | Design Therapeutics, Inc. | 644.59M | -3.56% | 24,526 | - |
| 189 | APMD | Apnimed, Inc. | 641.11M | -6.10% | 245,891 | 115.12M |
| 190 | SLDB | Solid Biosciences Inc. | 639.06M | -3.87% | 380,937 | - |
| 191 | FDMT | 4D Molecular Therapeutics, Inc. | 635.31M | -3.36% | 267,568 | 92.01M |
| 192 | LXRX | Lexicon Pharmaceuticals, Inc. | 629.61M | -0.35% | 694,463 | 41.47M |
| 193 | ANL | Adlai Nortye Group Ltd. | 628.52M | 2.20% | 134,718 | 18.06M |
| 194 | AURA | Aura Biosciences, Inc. | 628.45M | -1.30% | 303,884 | - |
| 195 | CADL | Candel Therapeutics, Inc. | 621.33M | -2.52% | 245,862 | - |
| 196 | IAM | Iambic Therapeutics, Inc. | 613.84M | -3.57% | 207,018 | 18.25M |
| 197 | NVCT | Nuvectis Pharma, Inc. | 611.23M | 1.52% | 99,483 | - |
| 198 | IMMX | Immix Biopharma, Inc. | 610.99M | -4.04% | 531,625 | - |
| 199 | ZVRA | Zevra Therapeutics, Inc. | 604.53M | -0.97% | 183,473 | 136.07M |
| 200 | ACRS | Aclaris Therapeutics, Inc. | 601.34M | -2.27% | 481,576 | 8.22M |
| 201 | OLMA | Olema Pharmaceuticals, Inc. | 596.73M | -2.57% | 134,294 | - |
| 202 | GERN | Geron Corporation | 579.90M | 0.92% | 4,865,252 | 204.56M |
| 203 | DBVT | DBV Technologies S.A. | 573.79M | -3.79% | 112,049 | 3.76M |
| 204 | CLYM | Climb Bio, Inc. | 563.45M | -4.29% | 556,196 | - |
| 205 | BCAX | Bicara Therapeutics Inc. | 550.56M | -8.87% | 678,946 | - |
| 206 | CBIO | Crescent Biopharma, Inc. | 549.57M | -4.75% | 24,689 | 11.88M |
| 207 | DRUG | Bright Minds Biosciences Inc. | 544.36M | -58.26% | 836,272 | - |
| 208 | NGNE | Neurogene Inc. | 542.81M | -1.54% | 24,177 | 925.00K |
| 209 | PBYI | Puma Biotechnology, Inc. | 534.27M | -0.86% | 83,260 | 231.24M |
| 210 | STTK | Shattuck Labs, Inc. | 533.93M | -4.32% | 108,763 | 1.00M |
| 211 | ENTX | Entera Bio Ltd. | 523.51M | -5.94% | 33,789 | 42.00K |
| 212 | MDXG | MiMedx Group, Inc. | 515.12M | -9.02% | 739,778 | 303.73M |
| 213 | VALN | Valneva SE | 506.57M | -2.48% | 4,499 | 163.30M |
| 214 | INDP | Indaptus Therapeutics, Inc. | 499.14M | 5.18% | 30,973 | - |
| 215 | GYRE | Gyre Therapeutics, Inc. | 498.89M | 3.29% | 48,299 | 109.82M |
| 216 | SRZN | Surrozen, Inc. | 495.99M | -2.38% | 64,596 | 11.51M |
| 217 | ARVN | Arvinas, Inc. | 491.70M | -4.33% | 386,980 | 316.70M |
| 218 | DMAC | DiaMedica Therapeutics Inc. | 491.26M | -1.51% | 16,596 | - |
| 219 | OCS | Oculis Holding AG | 486.45M | -4.60% | 61,298 | 1.45M |
| 220 | FTH | Faeth Therapeutics, Inc. | 484.12M | 0.24% | 62,279 | - |
| 221 | OVID | Ovid Therapeutics Inc. | 481.41M | -2.95% | 1,116,957 | 1.58M |
| 222 | CTMX | CytomX Therapeutics, Inc. | 480.47M | -5.77% | 3,127,228 | 18.30M |
| 223 | RGNX | REGENXBIO Inc. | 470.01M | -1.11% | 331,600 | 174.48M |
| 224 | PHAT | Phathom Pharmaceuticals, Inc. | 459.11M | 0.70% | 1,487,606 | 274.88M |
| 225 | ETRA | Electra Therapeutics, Inc. | 452.55M | -10.99% | 152,638 | - |
| 226 | MNPR | Monopar Therapeutics Inc. | 445.02M | -5.72% | 130,345 | - |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 442.44M | -1.61% | 71,605 | - |
| 228 | CRMD | CorMedix Inc. | 427.52M | -3.69% | 1,682,591 | 462.25M |
| 229 | PRTA | Prothena Corporation plc | 421.73M | -3.01% | 124,198 | 54.53M |
| 230 | YDES | YD Bio Limited | 421.45M | 0.17% | 15,451 | 1.24M |
| 231 | EDIT | Editas Medicine, Inc. | 409.29M | -0.19% | 393,475 | 47.01M |
| 232 | RLMD | Relmada Therapeutics, Inc. | 408.01M | 6.84% | 677,050 | - |
| 233 | CAPR | Capricor Therapeutics, Inc. | 403.19M | 8.70% | 2,712,671 | 11.13M |
| 234 | CCCC | C4 Therapeutics, Inc. | 401.68M | -3.12% | 1,025,593 | 35.04M |
| 235 | BLSM | BlossomHill Therapeutics, Inc. | 400.49M | -8.36% | 65,750 | - |
| 236 | ALT | Altimmune, Inc. | 398.76M | 0.49% | 895,732 | 31.00K |
| 237 | ASMB | Assembly Biosciences, Inc. | 398.05M | -2.88% | 80,274 | 74.85M |
| 238 | RZLT | Rezolute, Inc. | 397.03M | -4.18% | 312,607 | - |
| 239 | MPLT | MapLight Therapeutics, Inc. | 392.36M | -6.86% | 61,642 | - |
| 240 | PRLD | Prelude Therapeutics Incorporated | 391.38M | -2.06% | 31,613 | 22.42M |
| 241 | ASPE | Aspen Neuroscience, Inc. | 387.62M | -10.48% | 52,138 | - |
| 242 | AVTX | Avalo Therapeutics, Inc. | 382.92M | -0.42% | 524,748 | 59.00K |
| 243 | AUTL | Autolus Therapeutics plc | 380.61M | -5.92% | 1,858,833 | 117.39M |
| 244 | ALLO | Allogene Therapeutics, Inc. | 378.31M | -7.20% | 4,625,706 | 4.64M |
| 245 | ZURA | Zura Bio Limited | 373.26M | -4.08% | 1,906,171 | - |
| 246 | TECX | Tectonic Therapeutic, Inc. | 367.04M | -5.08% | 58,579 | - |
| 247 | FENC | Fennec Pharmaceuticals Inc. | 363.30M | 1.17% | 11,956 | 59.22M |
| 248 | TRXB | TRex Bio, Inc. | 361.02M | -2.40% | 34,763 | - |
| 249 | CTNM | Contineum Therapeutics, Inc. | 351.76M | -0.43% | 55,100 | - |
| 250 | AGMB | AgomAb Therapeutics NV | 349.41M | -5.27% | 35,405 | - |
| 251 | OBIO | Orchestra BioMed Holdings, Inc. | 342.60M | -3.55% | 117,205 | 31.98M |
| 252 | GALT | Galectin Therapeutics Inc. | 338.85M | 1.20% | 27,786 | - |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 330.16M | -0.60% | 179,878 | 15.85M |
| 254 | KYTX | Kyverna Therapeutics, Inc. | 325.91M | -7.05% | 397,773 | - |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 324.03M | -1.70% | 106,701 | - |
| 256 | ALEC | Alector, Inc. | 317.27M | -3.17% | 319,083 | 13.86M |
| 257 | SPRY | ARS Pharmaceuticals, Inc. | 312.26M | -7.10% | 469,619 | 116.93M |
| 258 | SABS | SAB Biotherapeutics, Inc. | 304.80M | - | 135,387 | 114.70K |
| 259 | IRD | Opus Genetics, Inc. | 304.50M | -0.27% | 371,508 | 9.86M |
| 260 | VTVT | vTv Therapeutics Inc. | 303.78M | -2.86% | 4,753 | 36.84M |
| 261 | NAUT | Nautilus Biotechnology, Inc. | 301.87M | -13.19% | 4,092,501 | 424.00K |
| 262 | TTRX | Turn Therapeutics Inc. | 301.45M | -2.97% | 16,806 | - |
| 263 | ENTA | Enanta Pharmaceuticals, Inc. | 301.45M | -3.36% | 45,124 | 65.26M |
| 264 | PROK | ProKidney Corp. | 297.00M | -24.14% | 4,116,865 | 818.00K |
| 265 | BNTC | Benitec Biopharma Inc. | 295.81M | -2.97% | 164,159 | - |
| 266 | AGEN | Agenus Inc. | 293.98M | -4.53% | 258,709 | 132.69M |
| 267 | SCTX | Scribe Therapeutics Inc. | 291.74M | -0.06% | 183,198 | 33.30M |
| 268 | EIKN | Eikon Therapeutics, Inc. | 290.32M | 0.94% | 102,728 | - |
| 269 | VOGX | Vogenx, Inc. | 284.47M | -5.43% | 18,326 | - |
| 270 | ARCT | Arcturus Therapeutics Holdings Inc. | 283.09M | -9.70% | 330,602 | 29.37M |
| 271 | FULC | Fulcrum Therapeutics, Inc. | 280.77M | -0.81% | 473,662 | 80.00M |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 274.93M | -2.58% | 170,513 | 1.00 |
| 273 | VCRE | Vicore Pharma Holding AB (publ) | 272.86M | -1.84% | 2,452 | 412.09K |
| 274 | LYEL | Lyell Immunopharma, Inc. | 268.94M | -0.59% | 34,448 | 27.00K |
| 275 | IPSC | Century Therapeutics, Inc. | 268.90M | 1.02% | 112,024 | 109.16M |
| 276 | RCKT | Rocket Pharmaceuticals, Inc. | 266.20M | -0.61% | 719,003 | - |
| 277 | QTTB | Q32 Bio Inc. | 257.80M | -2.81% | 108,448 | 53.74M |
| 278 | BCYC | Bicycle Therapeutics plc | 254.79M | -0.68% | 101,808 | 83.53M |
| 279 | LCTX | Lineage Cell Therapeutics, Inc. | 254.17M | 0.50% | 866,755 | 13.08M |
| 280 | LXEO | Lexeo Therapeutics, Inc. | 253.10M | -1.75% | 454,846 | - |
| 281 | IFRX | InflaRx N.V. | 249.05M | 1.81% | 195,927 | -11.54K |
| 282 | OCGN | Ocugen, Inc. | 249.01M | 4.50% | 2,329,664 | 4.58M |
| 283 | LRMR | Larimar Therapeutics, Inc. | 248.95M | -3.44% | 191,905 | - |
| 284 | GLSI | Greenwich LifeSciences, Inc. | 248.06M | -2.93% | 37,724 | - |
| 285 | CAMP | Camp4 Therapeutics Corporation | 246.62M | -0.76% | 114,328 | 4.22M |
| 286 | FATE | Fate Therapeutics, Inc. | 243.83M | -2.16% | 702,361 | 6.49M |
| 287 | CABA | Cabaletta Bio, Inc. | 243.30M | -4.97% | 2,378,750 | - |
| 288 | CUVL | Clinuvel Pharmaceuticals Limited | 243.16M | -4.14% | 1,995 | 65.05M |
| 289 | ABEO | Abeona Therapeutics Inc. | 239.03M | -3.91% | 361,189 | 25.52M |
| 290 | IMRX | Immuneering Corporation | 229.26M | -5.47% | 270,271 | - |
| 291 | VNDA | Vanda Pharmaceuticals Inc. | 227.37M | -0.79% | 728,640 | 229.28M |
| 292 | EVMN | Evommune, Inc. | 224.29M | -8.17% | 154,026 | 10.00M |
| 293 | ELDN | Eledon Pharmaceuticals, Inc. | 213.93M | -5.05% | 330,964 | - |
| 294 | KRRO | Korro Bio, Inc. | 213.52M | 1.29% | 70,492 | 2.38M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 212.58M | -5.00% | 29,765 | 1.80M |
| 296 | KROS | Keros Therapeutics, Inc. | 210.37M | -3.89% | 41,063 | 15.01M |
| 297 | ACIU | AC Immune SA | 209.79M | -4.95% | 346,521 | 21.67M |
| 298 | PLX | Protalix BioTherapeutics, Inc. | 208.68M | - | 109,609 | 80.62M |
| 299 | INO | Inovio Pharmaceuticals, Inc. | 207.83M | 233.67% | 145,453,657 | 65.34K |
| 300 | ARTV | Artiva Biotherapeutics, Inc. | 205.34M | 0.24% | 425,040 | 251.00K |
| 301 | PYXS | Pyxis Oncology, Inc. | 202.48M | -6.35% | 345,554 | 11.04M |
| 302 | PALI | Palisade Bio, Inc. | 195.18M | -3.45% | 854,380 | 500.00K |
| 303 | DTIL | Precision BioSciences, Inc. | 194.31M | -0.28% | 46,633 | 45.06M |
| 304 | PRQR | ProQR Therapeutics N.V. | 193.34M | -1.44% | 297,659 | 21.05M |
| 305 | RNAC | Cartesian Therapeutics, Inc. | 192.42M | -2.00% | 26,841 | 1.48M |
| 306 | CGEN | Compugen Ltd. | 188.03M | 0.25% | 67,172 | 74.00M |
| 307 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 187.21M | -10.88% | 249,146 | - |
| 308 | ACOG | Alpha Cognition Inc. | 186.64M | -1.95% | 23,750 | 15.26M |
| 309 | ALXO | ALX Oncology Holdings Inc. | 181.83M | 7.79% | 505,942 | - |
| 310 | ZNTL | Zentalis Pharmaceuticals, Inc. | 180.35M | -2.81% | 307,654 | 26.87M |
| 311 | WHWK | Whitehawk Therapeutics, Inc. | 179.58M | -2.78% | 35,412 | 7.15M |
| 312 | UPB | Upstream Bio, Inc. | 176.91M | -5.28% | 299,408 | 3.16M |
| 313 | MDWD | MediWound Ltd. | 174.93M | 1.88% | 14,094 | 11.86M |
| 314 | ANTX | AN2 Therapeutics, Inc. | 171.32M | 0.22% | 139,221 | - |
| 315 | YARW | Yarrow Bioscience, Inc. | 169.76M | -8.32% | 178,815 | - |
| 316 | ORMP | Oramed Pharmaceuticals Inc. | 168.89M | -1.22% | 41,004 | 2.00M |
| 317 | IVVD | Invivyd, Inc. | 168.75M | -1.58% | 2,332,905 | 58.37M |
| 318 | SION | Sionna Therapeutics, Inc. | 167.29M | -4.39% | 134,439 | - |
| 319 | CNTN | Canton Strategic Holdings, Inc. | 166.53M | 7.18% | 375,584 | 1.50M |
| 320 | TRDA | Entrada Therapeutics, Inc. | 166.22M | 1.65% | 282,694 | 4.69M |
| 321 | PEPG | PepGen Inc. | 162.76M | -0.42% | 263,942 | - |
| 322 | MGNX | MacroGenics, Inc. | 157.02M | 2.71% | 272,546 | 175.14M |
| 323 | ADAG | Adagene Inc. | 153.76M | -8.76% | 53,039 | 9.29M |
| 324 | NGEN | NervGen Pharma Corp. | 153.76M | 4.38% | 93,686 | - |
| 325 | STRO | Sutro Biopharma, Inc. | 151.55M | 0.44% | 24,836 | 45.70M |
| 326 | VRXA | Veraxa Biotech AG | 149.19M | -7.46% | 17,177 | 29.54K |
| 327 | CUE | Cue Biopharma, Inc. | 147.83M | -2.49% | 49,098 | 37.66M |
| 328 | RNA | Atrium Therapeutics, Inc. | 146.94M | 3.87% | 121,737 | 35.84M |
| 329 | MSLE | Satellos Bioscience Inc. | 146.15M | 0.75% | 248 | - |
| 330 | TARA | Protara Therapeutics, Inc. | 143.90M | -1.81% | 112,334 | - |
| 331 | MENS | Jyong Biotech Ltd. | 142.53M | 2.13% | 11,932 | - |
| 332 | CMPX | Compass Therapeutics, Inc. | 139.17M | -1.74% | 626,905 | 850.00K |
| 333 | SPRB | Spruce Biosciences, Inc. | 131.21M | -1.58% | 23,674 | 697.00K |
| 334 | IPHA | Innate Pharma S.A. | 126.91M | -3.42% | 15,139 | 11.21M |
| 335 | MOLN | Molecular Partners AG | 126.50M | -5.87% | 377 | 856.30K |
| 336 | NBP | NovaBridge Biosciences | 125.86M | -9.21% | 231,109 | - |
| 337 | CDXS | Codexis, Inc. | 121.55M | -6.72% | 437,063 | 77.68M |
| 338 | FHTX | Foghorn Therapeutics Inc. | 120.55M | -2.40% | 368,036 | 36.74M |
| 339 | CHRS | Coherus Oncology, Inc. | 119.89M | -6.52% | 1,255,846 | 50.94M |
| 340 | NERV | Minerva Neurosciences, Inc. | 116.98M | 5.60% | 59,155 | - |
| 341 | OTLK | Outlook Therapeutics, Inc. | 115.91M | 1.71% | 797,214 | -1.16M |
| 342 | HURA | TuHURA Biosciences, Inc. | 115.66M | -5.96% | 214,365 | - |
| 343 | KZIA | Kazia Therapeutics Limited | 113.06M | -2.94% | 44,507 | 1.27M |
| 344 | EQ | Equillium, Inc. | 110.50M | 2.92% | 128,421 | 4.39M |
| 345 | AVXL | Anavex Life Sciences Corp. | 110.31M | - | 534,435 | - |
| 346 | NKTX | Nkarta, Inc. | 110.30M | -1.28% | 841,231 | - |
| 347 | HUMA | Humacyte, Inc. | 109.23M | -4.38% | 3,114,742 | 2.12M |
| 348 | PYPD | PolyPid Ltd. | 108.87M | -0.56% | 34,327 | - |
| 349 | ARMP | Armata Pharmaceuticals, Inc. | 108.20M | -11.28% | 29,042 | 5.54M |
| 350 | VYGR | Voyager Therapeutics, Inc. | 106.91M | 0.87% | 622,828 | 34.46M |
| 351 | ANIX | Anixa Biosciences, Inc. | 105.68M | -2.57% | 84,388 | - |
| 352 | BDTX | Black Diamond Therapeutics, Inc. | 104.85M | 2.53% | 128,949 | 70.00M |
| 353 | MIST | Milestone Pharmaceuticals Inc. | 103.22M | 0.34% | 258,400 | 2.34M |
| 354 | PMVP | PMV Pharmaceuticals, Inc. | 102.70M | 3.82% | 292,467 | - |
| 355 | OKUR | OnKure Therapeutics, Inc. | 102.46M | -3.44% | 120,164 | - |
| 356 | PDSB | PDS Biotechnology Corporation | 102.19M | -2.08% | 2,190,293 | - |
| 357 | TENX | Tenax Therapeutics, Inc. | 101.96M | -0.56% | 567,454 | - |
| 358 | CBUS | Cibus, Inc. | 100.88M | 2.32% | 13,140 | 4.35M |
| 359 | IMUX | Immunic, Inc. | 100.83M | -1.60% | 122,873 | - |
| 360 | NRXP | NRx Pharmaceuticals, Inc. | 99.94M | 1.76% | 1,417,015 | 3.39M |
| 361 | ENGN | enGene Therapeutics Inc. | 99.85M | -2.61% | 210,516 | - |
| 362 | VANI | Vivani Medical, Inc. | 99.22M | 0.92% | 19,346 | - |
| 363 | RTSN | Retension Pharmaceuticals, Inc. | 94.98M | 0.35% | 53,597 | - |
| 364 | ICCC | ImmuCell Corporation | 94.91M | 1.85% | 887 | 30.68M |
| 365 | SEER | Seer, Inc. | 93.86M | 0.89% | 119,483 | 14.22M |
| 366 | UNCY | Unicycive Therapeutics, Inc. | 93.73M | -10.03% | 1,359,486 | - |
| 367 | TVGN | Tevogen Inc. | 93.40M | 0.60% | 1,182 | - |
| 368 | LENZ | LENZ Therapeutics, Inc. | 91.75M | -4.26% | 1,637,867 | 12.36M |
| 369 | GNLX | Genelux Corporation | 90.52M | -2.88% | 34,410 | 8.00K |
| 370 | NRXS | NeurAxis, Inc. | 87.90M | -1.82% | 25,487 | 5.32M |
| 371 | TNXP | Tonix Pharmaceuticals Holding Corp. | 87.81M | 0.39% | 196,336 | 29.10M |
| 372 | CLLS | Cellectis S.A. | 86.60M | 2.78% | 2,588 | 63.82M |
| 373 | PLYX | Polaryx Therapeutics, Inc. | 86.23M | -1.14% | 4,157 | - |
| 374 | TLSA | Tiziana Life Sciences Ltd | 86.10M | -15.94% | 547,379 | - |
| 375 | RLYB | Rallybio Corporation | 85.71M | 2.45% | 40,571 | 434.00K |
| 376 | NMRA | Neumora Therapeutics, Inc. | 84.74M | 22.82% | 1,384,212 | - |
| 377 | TNYA | Tenaya Therapeutics, Inc. | 84.58M | 2.67% | 1,419,078 | 1.34M |
| 378 | ATRA | Atara Biotherapeutics, Inc. | 83.41M | 3.75% | 16,512 | 6.19M |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 81.84M | -0.49% | 228,221 | 4.88M |
| 380 | COYA | Coya Therapeutics, Inc. | 79.05M | -6.65% | 31,978 | 8.02M |
| 381 | NTHI | NeOnc Technologies Holdings, Inc. | 78.80M | -2.76% | 61,095 | 39.99K |
| 382 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 77.75M | -4.74% | 267,943 | - |
| 383 | CNXU | Conexeu Sciences Inc. | 76.77M | -1.97% | 168,276 | - |
| 384 | NTRB | Nutriband Inc. | 76.40M | -0.24% | 7,106 | 1.62M |
| 385 | OKYO | OKYO Pharma Limited | 72.55M | -5.95% | 49,364 | - |
| 386 | ACRV | Acrivon Therapeutics, Inc. | 71.99M | 1.20% | 109,437 | - |
| 387 | CING | Cingulate Inc. | 71.62M | -1.10% | 49,352 | - |
| 388 | MNOV | MediciNova, Inc. | 70.88M | 2.86% | 28,965 | 920.48K |
| 389 | CGTX | Cognition Therapeutics, Inc. | 70.11M | 5.60% | 95,870 | - |
| 390 | CSBR | Champions Oncology, Inc. | 69.31M | 3.53% | 110 | 60.66M |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 68.22M | -0.91% | 31,486 | - |
| 392 | MAIA | MAIA Biotechnology, Inc. | 68.12M | 1.82% | 76,338 | - |
| 393 | CRDF | Cardiff Oncology, Inc. | 66.13M | -4.45% | 348,524 | 508.00K |
| 394 | FBIO | Fortress Biotech, Inc. | 63.37M | -1.04% | 40,901 | 68.47M |
| 395 | SPRO | Spero Therapeutics, Inc. | 61.15M | -0.94% | 237,640 | 47.00M |
| 396 | RNTX | Rein Therapeutics Inc. | 60.18M | 4.12% | 110,761 | - |
| 397 | GOSS | Gossamer Bio, Inc. | 58.72M | -7.51% | 30,275 | 53.29M |
| 398 | XBIT | XBiotech Inc. | 58.54M | 2.13% | 52,786 | - |
| 399 | VRCA | Verrica Pharmaceuticals Inc. | 57.44M | -0.19% | 25,440 | 30.32M |
| 400 | OSTX | OS Therapies Incorporated | 56.83M | -0.81% | 264,281 | - |
| 401 | RNXT | RenovoRx, Inc. | 55.96M | -6.77% | 121,129 | 1.98M |
| 402 | BOLD | Boundless Bio, Inc. | 55.16M | -1.82% | 27,650 | - |
| 403 | HRTX | Heron Therapeutics, Inc. | 54.92M | 4.18% | 384,976 | 151.18M |
| 404 | CLNN | Clene Inc. | 54.51M | 0.13% | 29,861 | 197.00K |
| 405 | ELOX | Eloxx Pharmaceuticals, Inc. | 54.09M | -0.37% | 15,276 | - |
| 406 | INKT | MiNK Therapeutics, Inc. | 53.33M | -0.76% | 4,537 | - |
| 407 | ALPS | Alps Group Inc | 53.23M | -1.57% | 35,038 | 3.74M |
| 408 | PLRX | Pliant Therapeutics, Inc. | 52.70M | -0.92% | 150,437 | - |
| 409 | ONCY | Oncolytics Biotech Inc. | 52.34M | -3.50% | 346,758 | - |
| 410 | XLO | Xilio Therapeutics, Inc. | 52.31M | -1.00% | 2,888 | 64.09M |
| 411 | HYFT | MindWalk Holdings Corp. | 52.29M | -1.77% | 76,847 | 11.57M |
| 412 | GANX | Gain Therapeutics, Inc. | 50.84M | 3.10% | 151,786 | - |
| 413 | SER | Serina Therapeutics, Inc. | 50.55M | 2.58% | 21,356 | 130.00K |
| 414 | IBIO | iBio, Inc. | 50.28M | 1.71% | 158,156 | 100.00K |
| 415 | HOWL | Werewolf Therapeutics, Inc. | 49.57M | 3.44% | 26,624 | 21.00M |
| 416 | CNTB | Connect Biopharma Holdings Limited | 49.29M | -2.43% | 206,976 | 2.95M |
| 417 | ANVS | Annovis Bio, Inc. | 48.14M | - | 2,100,961 | - |
| 418 | HYPD | Hyperion DeFi, Inc. | 48.09M | -3.88% | 32,594 | 1.40M |
| 419 | KLRS | Kalaris Therapeutics, Inc. | 47.85M | -0.99% | 34,897 | - |
| 420 | IMA | ImageneBio, Inc. | 46.54M | - | 675 | 800.00K |
| 421 | CRBU | Caribou Biosciences, Inc. | 46.41M | 2.29% | 1,657,413 | 10.04M |
| 422 | BMEA | Biomea Fusion, Inc. | 46.39M | 0.08% | 377,602 | - |
| 423 | MREO | Mereo BioPharma Group plc | 46.34M | 0.24% | 281,055 | 500.00K |
| 424 | TIL | Instil Bio, Inc. | 46.22M | 0.22% | 3,580 | - |
| 425 | ATNM | Actinium Pharmaceuticals, Inc. | 46.22M | -0.68% | 38,201 | 35.09M |
| 426 | APLM | Apollomics, Inc. | 45.44M | - | 3,322 | 8.84M |
| 427 | LONA | LeonaBio, Inc. | 44.28M | -4.86% | 19,095 | - |
| 428 | INMB | INmune Bio Inc. | 44.13M | -1.03% | 79,912 | 50.00K |
| 429 | PTHS | Pelthos Therapeutics Inc. | 42.34M | 17.66% | 80,233 | 43.30M |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 42.15M | -3.13% | 34,808 | - |
| 431 | ATHE | Alterity Therapeutics Limited | 41.96M | 2.08% | 2,710 | 2.50M |
| 432 | ELTX | Elicio Therapeutics, Inc. | 41.53M | -5.95% | 71,294 | - |
| 433 | EXOZ | eXoZymes, Inc. | 40.00M | 4.36% | 210 | -700.00 |
| 434 | GRCE | Grace Therapeutics, Inc. | 39.83M | -2.41% | 12,027 | - |
| 435 | ACET | Adicet Bio, Inc. | 36.71M | -0.29% | 104,946 | - |
| 436 | VERU | Veru Inc. | 36.15M | -3.20% | 61,289 | 16.89M |
| 437 | EDSA | Edesa Biotech, Inc. | 35.27M | 1.56% | 729 | - |
| 438 | NNVC | NanoViricides, Inc. | 35.21M | 3.72% | 20,514 | - |
| 439 | GRDX | GridAI Technologies Corp. | 34.63M | -1.41% | 6,762 | - |
| 440 | IBO | Impact BioMedical Inc. | 34.26M | 5.53% | 18,257 | 35.00K |
| 441 | BYSI | BeyondSpring Inc. | 33.99M | 28.41% | 838,570 | 1.88M |
| 442 | ALDX | Aldeyra Therapeutics, Inc. | 33.51M | -0.86% | 403,809 | - |
| 443 | IRLA | IRulya Therapeutics Inc. | 32.68M | -2.47% | 27,856 | - |
| 444 | EYPT | EyePoint, Inc. | 32.35M | 7.69% | 2,540,309 | 2.79M |
| 445 | LITS | Lite Strategy, Inc. | 30.34M | -10.90% | 355,573 | - |
| 446 | MGX | Metagenomi Therapeutics, Inc. | 30.13M | 2.20% | 16,949 | 13.56M |
| 447 | ALGS | Aligos Therapeutics, Inc. | 29.41M | -1.87% | 8,635 | 31.52M |
| 448 | AARD | Aardvark Therapeutics, Inc. | 28.23M | -5.15% | 101,483 | - |
| 449 | FLNA | Filana Therapeutics, Inc. | 28.02M | -6.75% | 224,304 | - |
| 450 | RNAZ | TransCode Therapeutics, Inc. | 27.60M | - | 8,105 | - |
| 451 | PMN | ProMIS Neurosciences, Inc. | 27.35M | -7.85% | 3,056,129 | - |
| 452 | BCTX | BriaCell Therapeutics Corp. | 27.34M | 1.97% | 12,842 | - |
| 453 | CELU | Celularity Inc. | 27.13M | 4.49% | 64,440 | 18.67M |
| 454 | PLRZ | Polyrizon Ltd. | 26.71M | 2.33% | 38,543 | - |
| 455 | NXTC | NextCure, Inc. | 26.55M | -8.08% | 5,828 | - |
| 456 | ABVC | ABVC BioPharma, Inc. | 26.22M | 1.00% | 13,817 | 797.92K |
| 457 | EVAX | Evaxion A/S | 24.69M | 1.02% | 7,678 | 7.49M |
| 458 | CRVO | CervoMed Inc. | 24.34M | 0.63% | 192,971 | 331.30K |
| 459 | CVM | CEL-SCI Corporation | 24.10M | -0.72% | 41,701 | - |
| 460 | ATOS | Atossa Therapeutics, Inc. | 23.55M | 8.76% | 39,940 | - |
| 461 | BSEM | BioStem Technologies, Inc. | 22.67M | 8.93% | 136,416 | 34.59M |
| 462 | IMMP | Immutep Limited | 22.36M | -1.96% | 938 | 13.79M |
| 463 | QNRX | Quoin Pharmaceuticals, Ltd. | 21.67M | -0.66% | 5,495 | - |
| 464 | ESLA | Estrella Immunopharma, Inc. | 21.56M | -22.48% | 393,486 | - |
| 465 | RADX | Radiopharm Theranostics Limited | 21.29M | -1.85% | 22,996 | 8.90M |
| 466 | COCP | Cocrystal Pharma, Inc. | 21.00M | 9.55% | 4,180 | 330.00K |
| 467 | IGC | IGC Pharma, Inc. | 19.75M | 3.24% | 268,784 | 1.11M |
| 468 | QNTM | Quantum BioPharma Ltd. | 19.39M | -3.78% | 18,074 | - |
| 469 | MCRB | Seres Therapeutics, Inc. | 19.07M | 7.24% | 38,305 | 1.88M |
| 470 | KYNB | Kyntra Bio, Inc. | 18.93M | 2.30% | 422 | 4.62M |
| 471 | AKTX | Akari Therapeutics, Plc | 18.78M | -0.24% | 8,457 | - |
| 472 | ACTU | Actuate Therapeutics, Inc. | 18.70M | 1.46% | 69,840 | - |
| 473 | CNTX | Context Therapeutics Inc. | 18.59M | 6.98% | 406,872 | - |
| 474 | ABOS | Acumen Pharmaceuticals, Inc. | 18.23M | 19.99% | 24,586,987 | - |
| 475 | JSPR | Jasper Therapeutics, Inc. | 17.52M | 1.24% | 125,962 | - |
| 476 | NEUP | Neuphoria Therapeutics Inc. | 16.50M | - | 2,023 | 1.17M |
| 477 | ATYR | aTyr Pharma, Inc. | 15.45M | 27.53% | 244,538 | 190.00K |
| 478 | CTXR | Citius Pharmaceuticals, Inc. | 15.07M | 4.95% | 62,778 | 7.11M |
| 479 | MRKR | Marker Therapeutics, Inc. | 15.06M | -7.83% | 68,541 | 3.55M |
| 480 | PLUR | Pluri Inc. | 15.06M | -1.61% | 60,408 | 1.02M |
| 481 | NCEL | NewcelX Ltd. | 14.50M | -1.57% | 5,985 | - |
| 482 | AEON | AEON Biopharma, Inc. | 14.46M | 5.80% | 242,153 | - |
| 483 | ALLR | Allarity Therapeutics, Inc. | 14.32M | 3.39% | 56,179 | 345.00K |
| 484 | DYAI | Dyadic International, Inc. | 13.85M | -0.05% | 15,603 | 3.80M |
| 485 | CNSY | Cerenome, Inc. | 13.74M | 6.47% | 24,164 | 4.20M |
| 486 | DARE | Daré Bioscience, Inc. | 13.48M | -2.02% | 105,123 | 1.37M |
| 487 | BCDA | BioCardia, Inc. | 13.33M | 2.26% | 29,928 | 3.00K |
| 488 | HIND | Vyome Holdings, Inc. | 13.27M | 5.00% | 5,412 | 129.73K |
| 489 | GUTS | Fractyl Health, Inc. | 12.99M | 0.30% | 110,164 | 3.00K |
| 490 | PBM | Psyence Biomedical Ltd. | 12.89M | 2.11% | 4,428 | - |
| 491 | TCRX | TScan Therapeutics, Inc. | 12.67M | 7.11% | 352,315 | 7.11M |
| 492 | KTTA | Pasithea Therapeutics Corp. | 12.37M | -0.04% | 131,230 | - |
| 493 | BOLT | Bolt Biotherapeutics, Inc. | 12.17M | -4.10% | 3,392 | 4.70M |
| 494 | LPCN | Lipocine Inc. | 12.12M | 2.08% | 111,071 | 1.57M |
| 495 | ICU | SeaStar Medical Holding Corporation | 11.73M | -0.45% | 38,234 | 1.71M |
| 496 | CLRB | Cellectar Biosciences, Inc. | 11.58M | 1.66% | 9,924 | - |
| 497 | KPRX | Kiora Pharmaceuticals, Inc. | 11.40M | 14.85% | 116,346 | 20.00K |
| 498 | INTS | Intensity Therapeutics, Inc. | 11.33M | 2.06% | 1,508 | - |
| 499 | PASG | Passage Bio, Inc. | 11.13M | 0.29% | 121 | - |
| 500 | GDTC | CytoMed Therapeutics Limited | 10.98M | 0.13% | 71 | 609.73K |